← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Bioio, Llc
Saint Louis, MO
$1,940,850
Total funding
2
Grants
Funding over time
peak $722K · FY2019–22$1M$750K$500K$250K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$1,940,850 · 2
By mechanism
R42$1,716,395 · 1
R41$224,455 · 1
Investigators at Bioio, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Novel insulin-sensitizing NASH/diabetes drugs.$497,526
R42 · FY2022 · DK
Novel insulin-sensitizing NASH/diabetes drugs.$497,526
R42 · FY2020 · DK
Novel insulin-sensitizing NASH/diabetes drugs.$497,526
R42 · FY2021 · DK
Drug target identification using CRISPRi/a screening$224,455
R41 · FY2020 · GM
Novel insulin-sensitizing NASH/diabetes drugs.$223,817
R42 · FY2019 · DK